Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities    
Net income (loss) $ 37,134,631 $ (2,459,571)
Adjustments to reconcile net income (loss) to net cash used in operating activities    
Depreciation expense 8,260 8,502
Gain on debt extinguishment (40,802,730) (2,434,661)
Decrease in fair value of derivative liabilities 0 (618)
Amortization of discount on notes payable 1,261,156 1,447,400
Accrued interest on patents purchased 0 123,233
Amortization of patents and acquired contracts 776,745 811,989
Stock-based compensation 249,020 393,456
Changes in operating assets and liabilities    
Accounts receivable 14,824 4,966
Prepaid expenses and other current assets, net 452,017 (24,140)
Deferred expenses 97,409 (34,877)
Accounts payable 78,701 (384,683)
Accrued expenses and other current liabilities 185,077 405,555
Deferred revenue (1,246,429) 300,000
Net cash used in operating activities (1,791,319) (1,843,449)
Cash flows from financing activities    
Proceeds from issuance of preferred stock, net of issuance costs 0 2,425,000
Proceeds from issuance of common stock, net of issuance costs 0 1,182,278
Proceeds from short-term notes payable, related party 385,000 0
Payments on senior notes payable 0 (1,640,016)
Payments on related party note payable 0 (50,000)
Net cash provided by financing activities 385,000 1,917,262
Net increase (decrease) in cash and cash equivalents (1,406,319) 73,813
Cash and cash equivalents, beginning of period 1,476,774 554,556
Cash and cash equivalents, end of period 70,455 628,369
Supplemental disclosures of cash flow information    
Cash paid for interest 0 426,249
Supplemental disclosures of non-cash investing and financing activities    
Fair value of common stock warrants $ 341,535 $ 1,481,978